| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.51e-06 | 32 | 53 | 4 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 2.87e-06 | 11 | 53 | 3 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 4.59e-06 | 42 | 53 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | nerve growth factor binding | 1.92e-04 | 8 | 53 | 2 | GO:0048406 | |
| GeneOntologyMolecularFunction | neurotrophin binding | 4.49e-04 | 12 | 53 | 2 | GO:0043121 | |
| GeneOntologyBiologicalProcess | nerve growth factor production | 1.94e-05 | 3 | 53 | 2 | GO:0032902 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 6.84e-05 | 31 | 53 | 3 | GO:0098974 | |
| GeneOntologyBiologicalProcess | neurotrophin production | 9.65e-05 | 6 | 53 | 2 | GO:0032898 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 9.89e-05 | 35 | 53 | 3 | GO:0099188 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 7.25e-05 | 32 | 53 | 3 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 7.25e-05 | 32 | 53 | 3 | GO:0043189 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 2.03e-04 | 45 | 53 | 3 | GO:1902562 | |
| Domain | PDEase_PDE8 | 7.31e-06 | 2 | 51 | 2 | IPR013938 | |
| Domain | Actin_CS | 1.05e-05 | 16 | 51 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 1.27e-05 | 17 | 51 | 3 | PS00432 | |
| Domain | Actin/actin-like_CS | 1.52e-05 | 18 | 51 | 3 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 1.80e-05 | 19 | 51 | 3 | PS01132 | |
| Domain | Ank_2 | 2.54e-05 | 215 | 51 | 6 | PF12796 | |
| Domain | - | 5.63e-05 | 248 | 51 | 6 | 1.25.40.20 | |
| Domain | ANK | 6.02e-05 | 251 | 51 | 6 | SM00248 | |
| Domain | ANK_REPEAT | 6.29e-05 | 253 | 51 | 6 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 6.43e-05 | 254 | 51 | 6 | IPR020683 | |
| Domain | ANK_REP_REGION | 6.43e-05 | 254 | 51 | 6 | PS50297 | |
| Domain | Ankyrin_rpt | 7.63e-05 | 262 | 51 | 6 | IPR002110 | |
| Domain | Actin | 8.17e-05 | 31 | 51 | 3 | IPR004000 | |
| Domain | Actin | 8.17e-05 | 31 | 51 | 3 | PF00022 | |
| Domain | ACTIN | 8.17e-05 | 31 | 51 | 3 | SM00268 | |
| Domain | Peptidase_S8_Asp-AS | 1.09e-04 | 6 | 51 | 2 | IPR023827 | |
| Domain | SAM_DOMAIN | 1.31e-04 | 95 | 51 | 4 | PS50105 | |
| Domain | SAM | 1.42e-04 | 97 | 51 | 4 | IPR001660 | |
| Domain | PrprotnconvertsP | 1.52e-04 | 7 | 51 | 2 | IPR002884 | |
| Domain | P_proprotein | 1.52e-04 | 7 | 51 | 2 | PF01483 | |
| Domain | S8_pro-domain | 1.52e-04 | 7 | 51 | 2 | IPR032815 | |
| Domain | - | 1.52e-04 | 7 | 51 | 2 | 3.30.70.850 | |
| Domain | S8_pro-domain | 1.52e-04 | 7 | 51 | 2 | PF16470 | |
| Domain | - | 1.99e-04 | 106 | 51 | 4 | 1.10.150.50 | |
| Domain | Peptidase_S8_His-AS | 2.60e-04 | 9 | 51 | 2 | IPR022398 | |
| Domain | Peptidase_S8_Ser-AS | 2.60e-04 | 9 | 51 | 2 | IPR023828 | |
| Domain | SAM/pointed | 2.91e-04 | 117 | 51 | 4 | IPR013761 | |
| Domain | Peptidase_S8_subtilisin-rel | 3.24e-04 | 10 | 51 | 2 | IPR015500 | |
| Domain | SUBTILASE_ASP | 3.24e-04 | 10 | 51 | 2 | PS00136 | |
| Domain | SUBTILASE_HIS | 3.24e-04 | 10 | 51 | 2 | PS00137 | |
| Domain | SUBTILASE_SER | 3.24e-04 | 10 | 51 | 2 | PS00138 | |
| Domain | Ank | 3.86e-04 | 228 | 51 | 5 | PF00023 | |
| Domain | - | 3.96e-04 | 11 | 51 | 2 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 3.96e-04 | 11 | 51 | 2 | IPR000209 | |
| Domain | Peptidase_S8 | 3.96e-04 | 11 | 51 | 2 | PF00082 | |
| Domain | Propept_inh | 9.68e-04 | 17 | 51 | 2 | IPR009020 | |
| Domain | Furin_repeat | 1.09e-03 | 18 | 51 | 2 | IPR006212 | |
| Domain | FU | 1.09e-03 | 18 | 51 | 2 | SM00261 | |
| Domain | PLAC | 1.21e-03 | 19 | 51 | 2 | PS50900 | |
| Domain | PLAC | 1.21e-03 | 19 | 51 | 2 | IPR010909 | |
| Domain | PDEase | 1.21e-03 | 19 | 51 | 2 | IPR023088 | |
| Domain | PDEase_I | 1.49e-03 | 21 | 51 | 2 | PF00233 | |
| Domain | PDEASE_I | 1.49e-03 | 21 | 51 | 2 | PS00126 | |
| Domain | PDEase_CS | 1.49e-03 | 21 | 51 | 2 | IPR023174 | |
| Domain | - | 1.63e-03 | 22 | 51 | 2 | 1.10.1300.10 | |
| Domain | PDEase_catalytic_dom | 1.78e-03 | 23 | 51 | 2 | IPR002073 | |
| Domain | SAM | 1.79e-03 | 88 | 51 | 3 | SM00454 | |
| Domain | HDc | 1.94e-03 | 24 | 51 | 2 | SM00471 | |
| Domain | HD/PDEase_dom | 1.94e-03 | 24 | 51 | 2 | IPR003607 | |
| Domain | PAS | 2.11e-03 | 25 | 51 | 2 | PF00989 | |
| Domain | PAS_fold | 2.11e-03 | 25 | 51 | 2 | IPR013767 | |
| Domain | Ig_E-set | 2.88e-03 | 104 | 51 | 3 | IPR014756 | |
| Domain | PAS | 3.44e-03 | 32 | 51 | 2 | SM00091 | |
| Domain | PAS | 3.88e-03 | 34 | 51 | 2 | IPR000014 | |
| Domain | PAS | 3.88e-03 | 34 | 51 | 2 | PS50112 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 2.01e-11 | 15 | 53 | 5 | 16824795 | |
| Pubmed | 2.40e-07 | 282 | 53 | 7 | 23667531 | ||
| Pubmed | 2.79e-07 | 9 | 53 | 3 | 16364570 | ||
| Pubmed | cAMP-specific phosphodiesterases 8A and 8B, essential regulators of Leydig cell steroidogenesis. | 2.28e-06 | 2 | 53 | 2 | 22232524 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 21187369 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 17909005 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 2.28e-06 | 2 | 53 | 2 | 19669888 | |
| Pubmed | Enhanced UV-induced skin carcinogenesis in transgenic mice overexpressing proprotein convertases. | 2.28e-06 | 2 | 53 | 2 | 23441131 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 1741956 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 12681444 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 36277728 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 4.90e-06 | 847 | 53 | 9 | 35235311 | |
| Pubmed | 5.09e-06 | 163 | 53 | 5 | 24316575 | ||
| Pubmed | DDX19B HDAC3 ZNF384 ARHGDIA THYN1 HSPH1 NAP1L1 TNPO3 HEXIM1 DNMT1 | 5.58e-06 | 1103 | 53 | 10 | 34189442 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 8670066 | ||
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 6.83e-06 | 3 | 53 | 2 | 17101985 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 10050053 | ||
| Pubmed | CDMP1/GDF5 has specific processing requirements that restrict its action to joint surfaces. | 1.36e-05 | 4 | 53 | 2 | 16829522 | |
| Pubmed | Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. | 1.36e-05 | 4 | 53 | 2 | 8615794 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 12787574 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 26283733 | ||
| Pubmed | The proprotein convertases furin and PACE4 play a significant role in tumor progression. | 1.36e-05 | 4 | 53 | 2 | 10900462 | |
| Pubmed | Retroviral envelope glycoprotein processing: structural investigation of the cleavage site. | 1.36e-05 | 4 | 53 | 2 | 9521771 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.48e-05 | 736 | 53 | 8 | 29676528 | |
| Pubmed | Cripto recruits Furin and PACE4 and controls Nodal trafficking during proteolytic maturation. | 2.27e-05 | 5 | 53 | 2 | 18772886 | |
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 18664504 | ||
| Pubmed | Processing of prothyrotropin-releasing hormone by the family of prohormone convertases. | 2.27e-05 | 5 | 53 | 2 | 9242664 | |
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 11380615 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 1429684 | ||
| Pubmed | 2.30e-05 | 36 | 53 | 3 | 22422068 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ZNF384 ARHGDIA MDN1 PI4KA ACO2 HSPH1 POLR2C NAP1L1 LARP4 DNMT1 | 3.26e-05 | 1353 | 53 | 10 | 29467282 |
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 8940009 | ||
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 17171436 | ||
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 9291583 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SLC7A6OS HSPH1 POLR2C CAST NAP1L1 RCN1 ZNF622 LARP4 HEXIM1 DNMT1 | 4.75e-05 | 1415 | 53 | 10 | 28515276 |
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 15276201 | ||
| Pubmed | HDAC2/3 binding and deacetylation of BubR1 initiates spindle assembly checkpoint silencing. | 4.76e-05 | 7 | 53 | 2 | 28985013 | |
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 10409610 | ||
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 7819324 | ||
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 15505202 | ||
| Pubmed | POTEE MDN1 POTEF ACO2 CTAGE1 HSPH1 RCN1 DNAJC5 POTEI DYNC1I1 | 5.57e-05 | 1442 | 53 | 10 | 35575683 | |
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 7782070 | ||
| Pubmed | Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. | 6.34e-05 | 8 | 53 | 2 | 9885250 | |
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 10037747 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DDX19B POTEE HDAC3 NDUFB11 MDN1 PI4KA ACO2 MRPL30 ZNF622 LARP4 | 7.57e-05 | 1496 | 53 | 10 | 32877691 |
| Pubmed | POTEE HDAC3 MDN1 NFATC2 PI4KA HSPH1 POLR2C NAP1L1 ZNF622 HEXIM1 | 7.61e-05 | 1497 | 53 | 10 | 31527615 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 7.80e-05 | 288 | 53 | 5 | 31501420 | |
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 18241125 | ||
| Pubmed | The activation and physiological functions of the proprotein convertases. | 8.15e-05 | 9 | 53 | 2 | 18343183 | |
| Pubmed | The prohormone theory and the proprotein convertases: it is all about serendipity. | 8.15e-05 | 9 | 53 | 2 | 21805236 | |
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 21805237 | ||
| Pubmed | The biology and therapeutic targeting of the proprotein convertases. | 8.15e-05 | 9 | 53 | 2 | 22679642 | |
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 23775089 | ||
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 8698813 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 1.01e-04 | 714 | 53 | 7 | 28302793 | |
| Pubmed | 1.02e-04 | 10 | 53 | 2 | 16163737 | ||
| Pubmed | 1.02e-04 | 10 | 53 | 2 | 26416966 | ||
| Pubmed | Nfix regulates fetal-specific transcription in developing skeletal muscle. | 1.24e-04 | 11 | 53 | 2 | 20178747 | |
| Pubmed | 1.34e-04 | 1293 | 53 | 9 | 15342556 | ||
| Pubmed | 1.37e-04 | 1297 | 53 | 9 | 33545068 | ||
| Pubmed | 1.65e-04 | 538 | 53 | 6 | 28524877 | ||
| Pubmed | 1.70e-04 | 1335 | 53 | 9 | 29229926 | ||
| Pubmed | 2.26e-04 | 77 | 53 | 3 | 19505873 | ||
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 2.26e-04 | 195 | 53 | 4 | 17110338 | |
| Pubmed | 2.36e-04 | 15 | 53 | 2 | 21406692 | ||
| Pubmed | Imaging proprotein convertase activities and their regulation in the implanting mouse blastocyst. | 2.70e-04 | 16 | 53 | 2 | 20876279 | |
| Pubmed | 2.72e-04 | 82 | 53 | 3 | 20833797 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 2.76e-04 | 1425 | 53 | 9 | 30948266 | |
| Pubmed | NDUFB11 ARHGDIA PI4KA ACO2 HSPH1 NAP1L1 PEAK1 SHANK3 DYNC1I1 | 2.85e-04 | 1431 | 53 | 9 | 37142655 | |
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 2.97e-04 | 384 | 53 | 5 | 31059266 | |
| Pubmed | 3.05e-04 | 17 | 53 | 2 | 12601813 | ||
| Pubmed | 3.13e-04 | 606 | 53 | 6 | 36538041 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 3.18e-04 | 861 | 53 | 7 | 36931259 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 3.22e-04 | 1455 | 53 | 9 | 22863883 | |
| Pubmed | 3.24e-04 | 87 | 53 | 3 | 33711283 | ||
| Pubmed | 3.35e-04 | 88 | 53 | 3 | 21491433 | ||
| Pubmed | 3.38e-04 | 615 | 53 | 6 | 31048545 | ||
| Pubmed | 3.77e-04 | 1487 | 53 | 9 | 33957083 | ||
| Pubmed | 3.83e-04 | 224 | 53 | 4 | 32941674 | ||
| Pubmed | Daxx Inhibits HIV-1 Reverse Transcription and Uncoating in a SUMO-Dependent Manner. | 3.83e-04 | 19 | 53 | 2 | 32545337 | |
| Pubmed | 3.83e-04 | 19 | 53 | 2 | 16950123 | ||
| Pubmed | 3.98e-04 | 634 | 53 | 6 | 34591612 | ||
| Pubmed | 4.25e-04 | 20 | 53 | 2 | 23918928 | ||
| Pubmed | Loss of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic patterning. | 4.25e-04 | 20 | 53 | 2 | 15829518 | |
| Pubmed | 4.32e-04 | 96 | 53 | 3 | 23580065 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 4.42e-04 | 647 | 53 | 6 | 26618866 | |
| Pubmed | Extraembryonic proteases regulate Nodal signalling during gastrulation. | 4.70e-04 | 21 | 53 | 2 | 12447384 | |
| Pubmed | Sall4 isoforms act during proximal-distal and anterior-posterior axis formation in the mouse embryo. | 4.70e-04 | 21 | 53 | 2 | 18781635 | |
| Pubmed | CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1. | 5.01e-04 | 101 | 53 | 3 | 34462429 | |
| Pubmed | 5.16e-04 | 22 | 53 | 2 | 21896659 | ||
| Pubmed | 5.16e-04 | 22 | 53 | 2 | 25331947 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 5.18e-04 | 934 | 53 | 7 | 33916271 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | 5.63e-04 | 442 | 53 | 5 | 15815621 | |
| Pubmed | 5.65e-04 | 23 | 53 | 2 | 21670149 | ||
| Pubmed | 5.65e-04 | 23 | 53 | 2 | 21360054 | ||
| Pubmed | 6.02e-04 | 686 | 53 | 6 | 28380382 | ||
| Pubmed | 6.02e-04 | 686 | 53 | 6 | 29987050 | ||
| Pubmed | 6.16e-04 | 24 | 53 | 2 | 11258795 | ||
| Pubmed | 6.52e-04 | 971 | 53 | 7 | 33306668 | ||
| Pubmed | 6.68e-04 | 25 | 53 | 2 | 17307970 | ||
| Interaction | ACTG2 interactions | 7.66e-06 | 49 | 52 | 4 | int:ACTG2 | |
| Interaction | DNAJC7 interactions | 1.22e-05 | 425 | 52 | 8 | int:DNAJC7 | |
| Interaction | PFDN2 interactions | 4.05e-05 | 247 | 52 | 6 | int:PFDN2 | |
| Interaction | SOX2 interactions | HDAC3 ZNF384 ARHGDIA TSHZ3 INTS14 MDN1 NFIA PI4KA POLR2C NAP1L1 RCN1 PBX4 TNPO3 | 4.81e-05 | 1422 | 52 | 13 | int:SOX2 |
| Interaction | SLC25A11 interactions | 4.84e-05 | 255 | 52 | 6 | int:SLC25A11 | |
| Cytoband | 2q21.1 | 4.29e-05 | 58 | 53 | 3 | 2q21.1 | |
| Cytoband | 13q12.3 | 2.98e-04 | 22 | 53 | 2 | 13q12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 7.24e-04 | 151 | 53 | 3 | chr2q21 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 4.55e-11 | 13 | 39 | 5 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | 1.22e-05 | 242 | 39 | 6 | 403 | |
| GeneFamily | Sterile alpha motif domain containing | 3.78e-05 | 88 | 39 | 4 | 760 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 1.62e-04 | 9 | 39 | 2 | 973 | |
| GeneFamily | Phosphodiesterases | 1.21e-03 | 24 | 39 | 2 | 681 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 8.50e-06 | 137 | 53 | 5 | M39241 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 9.71e-07 | 63 | 53 | 4 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic-platelet|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.38e-06 | 180 | 53 | 5 | beb4d777e0c5fa0a59672dbc3dbb7732498605ff | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.38e-06 | 180 | 53 | 5 | fb3d549c2a69b2157a486786ddd775ca16699ed0 | |
| ToppCell | COVID-19-kidney-T-cells-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.95e-06 | 188 | 53 | 5 | 15484c05cb496cd98ed3f79a6134c5cec8f09a4d | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.89e-06 | 199 | 53 | 5 | 5a29db2610ba06a2248325a16cad755d20debf2c | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.07e-06 | 90 | 53 | 4 | 96e836c7a1df279ac812b7c3aa75e6b81b614244 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 138 | 53 | 4 | 321070b6900887b27da0f2b25808a05a8ab89ee7 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 138 | 53 | 4 | 19ffd66256fa94d728138d37d0a5a3bac7722dbb | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-05 | 172 | 53 | 4 | 3a37569a5902f3c65ff8d3912421309a8c82ee9b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-05 | 172 | 53 | 4 | cc9d9dae290f11f8c348c78228af4e49469dc93b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.09e-05 | 179 | 53 | 4 | 021d782134126c6f7dce6b6ea50cc54bdaa39987 | |
| ToppCell | (1)_B_cells-(1)_B_CD27pos|(1)_B_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 6.36e-05 | 181 | 53 | 4 | d2476956ca13f9234d7e77c3ee432dd54eebeac4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-05 | 187 | 53 | 4 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.52e-05 | 189 | 53 | 4 | 284f39dfacec76004daae9dd5317fb7b1f04fa99 | |
| ToppCell | COVID-19-lung-CD8+_T_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.83e-05 | 191 | 53 | 4 | 543f8ae07cc2e6950c888115a5ca9445e3c0f618 | |
| ToppCell | COVID-19-kidney-T-cells-2|kidney / Disease (COVID-19 only), tissue and cell type | 7.83e-05 | 191 | 53 | 4 | 698e6a28276704f8baa082d028db2345b973c4bc | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.83e-05 | 191 | 53 | 4 | 29ce21c6e810edd51f13e0fb1083cd44bd57b1d4 | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.83e-05 | 191 | 53 | 4 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 7.83e-05 | 191 | 53 | 4 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 193 | 53 | 4 | 40eedc1490c113403bc7c12a6bdf976f4f8bca84 | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.15e-05 | 193 | 53 | 4 | 326fd2ce2c4b51e5a38f2a7a09f22f8f0e92735a | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 197 | 53 | 4 | eebf4c3e71efc17672801649eed1bf158b2a88e5 | |
| ToppCell | CD8+_Memory_T_cell-CV-3|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.83e-05 | 197 | 53 | 4 | 9fe3d53346a95c1bbb0fc6a2f2e974889873424b | |
| ToppCell | CV-Moderate-3|CV / Virus stimulation, Condition and Cluster | 8.83e-05 | 197 | 53 | 4 | 7031286e300eaccf73b927939f8de3a9d2d5fc74 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.00e-05 | 198 | 53 | 4 | 90863377ed36afc30bc1a068612ad1adc77af5a8 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.00e-05 | 198 | 53 | 4 | cc5ca64749e2f4f1d373d9472824df85741702b7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.00e-05 | 198 | 53 | 4 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.00e-05 | 198 | 53 | 4 | d4d66f19df078bfc3a83d4664aaf9c7789bde1a5 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-05 | 199 | 53 | 4 | fbdde57dd88656621801e65ee2818251588f3874 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-05 | 199 | 53 | 4 | 0d6463e368fd611a17327322413fad145f3c7f32 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | dfdfad881c114e1bc9a64b411e1b00fb37cc859b | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | 7a9c3f51d4a8fda5f1b7e0be6fcf9c1c92fffe99 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | c6c2b39359c65c9444987d02d1c899dff2ad1366 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | 8474e5d031d25bfb8461d39fa2053da01a6304fc | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | 66fb892bda1d29e67a65717e85f2ec221f520b2a | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | 02c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | c3511607692e05f44538a376253673dd18f77908 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | 893bb7c25ad7c6589a4c7c0364c2ace666e9b4be | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | 9de4d6ebb7e9bee5d811519eb05913ef30f70786 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | f7a9d8b99de19e9842422bada348d940e0863645 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | cded40d5069a6fdbd90ac9a2a0bbef11727b28d5 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | 510d84bf7a4621b079e5a7330d25e04508c84a49 | |
| ToppCell | wk_08-11-Mesenchymal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.36e-05 | 200 | 53 | 4 | 91416639e69621c5b36eebf061d81bccfe66f135 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | 1c58860932ed47263a5a537a64f0343201463c21 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | 9ef322486e46e4ff05a8cbe06cf8019e996c94b3 | |
| ToppCell | Biopsy_IPF-Immune-T_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 9.36e-05 | 200 | 53 | 4 | 368c7334d211054f1e914a1be4027aa75e2df66c | |
| Disease | Carcinomatosis | 1.44e-04 | 163 | 48 | 4 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.44e-04 | 163 | 48 | 4 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.44e-04 | 163 | 48 | 4 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.44e-04 | 163 | 48 | 4 | C0205696 | |
| Disease | Carcinoma | 1.48e-04 | 164 | 48 | 4 | C0007097 | |
| Disease | otosclerosis | 3.15e-04 | 81 | 48 | 3 | EFO_0004213 | |
| Disease | hormone measurement, thyroid stimulating hormone measurement | 1.02e-03 | 29 | 48 | 2 | EFO_0004730, EFO_0004748 | |
| Disease | eicosapentaenoic acid measurement | 1.17e-03 | 31 | 48 | 2 | EFO_0007760 | |
| Disease | Animal Mammary Neoplasms | 1.61e-03 | 142 | 48 | 3 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 1.61e-03 | 142 | 48 | 3 | C1257925 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EFDPGQDTYQHPPKD | 536 | Q99798 | |
| NSESEDGAYLDNPPK | 266 | Q96RT6 | |
| DDPDLKYGQHPPDAV | 361 | P26358 | |
| HPQPEDPAKESYQDA | 361 | P10523 | |
| QEPKPYSDDDEINGV | 381 | A4D256 | |
| NFHEDLSYGPSEEPD | 1071 | Q9UKP4 | |
| QPSDADIKDQPENGH | 196 | Q12857 | |
| GERPPEDNQSFQYDH | 46 | Q15293 | |
| EENDPDYDPKKDQNP | 371 | P55209 | |
| YEYLNPNEEEPNAHK | 36 | Q13469 | |
| LEHGTDPNIPDEYGN | 226 | A5A3E0 | |
| NEVDPYHGNQEKVPE | 4861 | Q9NU22 | |
| YHGNQEKVPEPEALD | 4866 | Q9NU22 | |
| EDLEDKNNFGAEPPH | 826 | Q92598 | |
| SYNNNEDAPHEPDGV | 306 | O14576 | |
| DDHDQEEPDLKTGLY | 211 | O94992 | |
| DGIERNHPDLAPNYD | 206 | P29122 | |
| EDDEGISHVPKPYGN | 121 | Q9H792 | |
| ELYSPQFGAKDDDPH | 426 | O60658 | |
| ELYSPQLGTKDEDPH | 486 | O95263 | |
| YLDEEGHQKDPDIGD | 1696 | P42356 | |
| KYHPDKNPDNPEAAD | 41 | Q9H3Z4 | |
| RPEAPNEFYDGDHDN | 406 | O15379 | |
| LEHGTDPNIPDEYGN | 226 | Q6S8J3 | |
| SHLNNPYPSEEAKEE | 231 | Q9BYU1 | |
| PYNSEPAEESEHKNN | 41 | P51587 | |
| AENEEDEHSVNYKPP | 16 | P52565 | |
| IEKNHPDLAGNYDPG | 156 | P09958 | |
| YHEPPEDDKASQRQF | 71 | P31415 | |
| PISDAKENPYGEDDN | 371 | Q96SY0 | |
| PVDKDGNPDNETYLH | 411 | Q9UMR2 | |
| PEYRHLLDDNGQDKP | 616 | P20810 | |
| NEDNGAPENSVEKPH | 651 | Q71RC2 | |
| EEKNEDHTPNYAPAN | 41 | Q9NQ60 | |
| DNSSHPQKDEGDNPE | 356 | P21453 | |
| PEDENLYEKNPDSHG | 61 | Q9NX14 | |
| FQASPEDHEKYGGDP | 46 | Q8TCC3 | |
| EDHEKYGGDPQNPHK | 51 | Q8TCC3 | |
| DHYAKDPDIEAPSNQ | 221 | Q7Z3H4 | |
| NHENLKGGDDLDPNY | 111 | P06732 | |
| ESDNHDPGQLDNSKP | 81 | Q8IVG5 | |
| EDGENAHPYRNSDPV | 96 | Q9NSI8 | |
| LEHGTDPNIPDEYGN | 226 | P0CG38 | |
| HPKPALDTGYETEQD | 806 | Q92854 | |
| LDEDESQAPYDPNGK | 211 | P19387 | |
| PLDVQKEFGYDSPHD | 291 | Q96CW6 | |
| YVLSPEDDDDHQKDG | 211 | Q8TF68 | |
| PDGQYHLKPEEVDDF | 626 | Q9UBZ9 | |
| DKGLDPNFHDPDSGE | 136 | Q9BYB0 | |
| DPEEHTADGEPSAKY | 31 | Q63HK5 | |
| QALYHDPDPSGKERA | 16 | Q9Y5L0 | |
| EKNNPHYDPSSKEDN | 141 | Q9P016 | |
| SSYPDHKEGEDPNKA | 351 | Q969S3 | |
| LEHGTDPNIPDEYGN | 226 | Q6S5H5 | |
| LEHGTDPNIPDEYGN | 226 | A6NI47 |